首页> 外文OA文献 >Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin as First-Line Chemotherapy

【2h】

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin as First-Line Chemotherapy

机译：伊立替康/顺铂与依托泊苷/顺铂一线化疗治疗的广泛期小细胞肺癌患者荟萃分析的补充和校正

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jiang Jingwei; Liang Xiaohua;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy. [J] . Guo S, Liang Y, Zhou Q Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2011,第2期

机译：伊立替康/顺铂与依托泊苷/顺铂一线化疗相比，对广泛期小细胞肺癌患者进行荟萃分析的补充和校正。
2. Irinotecan plus cisplatin compared with etoposide plus cisplatin in patients with previously untreated extensive-stage small cell lung cancer: A meta-analysis [J] . Zi-Li Liu, Bin Wang, Ji-Zhu Liu, Journal of Cancer Research and Therapeutics . 2018,第12期

机译：伊立替康联合顺铂与依托泊苷联合顺铂在先前未接受治疗的广泛期小细胞肺癌患者中的荟萃分析
3. Irinotecan plus cisplatin compared with etoposide plus cisplatin in patients with previously untreated extensive-stage small cell lung cancer: A meta-analysis [J] . Zi-Li Liu, Bin Wang, Ji-Zhu Liu, Journal of Cancer Research and Therapeutics . 2018,第12期

机译：伊立替康联合顺铂与依托泊苷联合顺铂在先前未接受治疗的广泛期小细胞肺癌患者中的荟萃分析
4. THE INHIBITION OF N-LINKED GLYCOSYLATION BREAKS THE RESISTANACE OF HUMAN OVARIAN CANCER CELLS TO CISPLATIN AND ETOPOSIDE [C] . Anna Macieia, Joanna Sarnik, Zbigniew J. Witczak International Carbohydrate Symposium . 2018

机译：N-连接的糖基化的抑制破坏了人卵巢癌细胞对顺铂和依托泊苷的抗性
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer [O] . Dong-Wan Kim, Hoon-Gu Kim, Joo-Hang Kim, 2019

机译：伊立替康联合顺铂与依托泊苷联合顺铂在未经化疗的韩国广泛性疾病小细胞肺癌患者中进行的随机III期试验
7. Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin as First-Line Chemotherapy [O] . Guo Shanxian, Liang Yonggang, Zhou Qinghua 2011

机译：伊立替康/顺铂与依托泊苷/顺铂一线化疗治疗的广泛期小细胞肺癌患者荟萃分析的补充和校正

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin as First-Line Chemotherapy

著录项

相似文献

相关主题

期刊订阅